ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,886.54
      -0.04%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Blueprint Medicines Corporation (BPMC)

      7. Blueprint Medicines Corporation (BPMC) Financials

      Blueprint Medicines Corporation

      Blueprint Medicines Corporation (BPMC)

      NASDAQ
      112.19
      -1.50
      (-1.32%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      112.19
      0.00
      ( 0.00% )
      After Hours: 6:56PM
      Delayed by 15 minutes

      Blueprint Medicines Corporation Financial Summary

      The current BPMC market cap is 7.02B. The company's latest EPS is USD -8.0966 and P/E is -13.86.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 63.29M57.57M56.57M71.96M96.12M
      Operating Income -124.21M-129.28M-128.98M-105.11M-78.82M
      Net Income -129.56M-132.79M-133.71M-110.92M89.14M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 66.51M793.74M180.08M204.04M249.38M
      Operating Income -361.33M308.71M-641.98M-537.52M-486.28M
      Net Income -347.69M313.88M-644.09M-557.52M-506.98M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.22B1.11B1.11B1.05B1.04B
      Total Liabilities 806.07M795.32M902.69M918.64M727.79M
      Total Equity 414.3M311.13M202.61M130.61M310.69M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 707.69M1.72B1.25B1.35B1.05B
      Total Liabilities 243.34M248.31M281.49M835.23M918.64M
      Total Equity 464.36M1.47B970.74M514.68M130.61M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -122.96M-253.44M-357.92M-436.85M-101.51M
      Investing 172.79M204.86M195.27M274.04M77.13M
      Financing N/A 5.3M103.7M119.23M66.96M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -278.02M387.04M-298.65M-502.28M-436.85M
      Investing -16.47M-434.25M-225.86M-149.54M274.04M
      Financing 340.64M617.76M50.72M561.81M119.23M

      Stats and Ratios

      Market Cap 7.02B
      Price to Earnings Ratio -13.86
      Price to Sales Ratio 28.17
      Price to Cash Ratio 98.55
      Price to Book Ratio 53.79
      Dividend Yield -

      Share Statistics

      Shares Outstanding 62.62M
      Average Volume (1 week) 543.97k
      Average Volume (1 Month) 607.62k
      52 Week Change 89.03%
      52 Week High 121.90
      52 Week Low 43.89
      Spread (Intraday) 11.98 (10.24%)

      Company Info

      Company Name Blueprint Medicines Corporation
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.blueprintmedicines.com
      Industry pharmaceutical preparations (2834)